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Abstract: Demineralized dentin matrix (DDM)-based materials have been actively developed and
are well-known for their excellent performance in dental tissue regeneration. However, DDM-based
bio-ink suitable for fabrication of engineered dental tissues that are patient-specific in terms of shape
and size, has not yet been developed. In this study, we developed a DDM particle-based bio-ink
(DDMp bio-ink) with enhanced three-dimensional (3D) printability. The bio-ink was prepared by
mixing DDM particles and a fibrinogen–gelatin mixture homogeneously. The effects of DDMp
concentration on the 3D printability of the bio-ink and dental cell compatibility were investigated. As
the DDMp concentration increased, the viscosity and shear thinning behavior of the bio-ink improved
gradually, which led to the improvement of the ink’s 3D printability. The higher the DDMp content,
the better were the printing resolution and stacking ability of the 3D printing. The printable minimum
line width of 10% w/v DDMp bio-ink was approximately 252 µm, whereas the fibrinogen–gelatin
mixture was approximately 363 µm. The ink’s cytocompatibility test with dental pulp stem cells
(DPSCs) exhibited greater than 95% cell viability. In addition, as the DDMp concentration increased,
odontogenic differentiation of DPSCs was significantly enhanced. Finally, we demonstrated that
cellular constructs with 3D patient-specific shapes and clinically relevant sizes could be fabricated
through co-printing of polycaprolactone and DPSC-laden DDMp bio-ink.
Keywords: demineralized dentin matrix; bio-ink; 3D bioprinting; dental tissue engineering
1. Introduction
In clinic, non-biological dental implants are commonly used to treat tooth loss. How-
ever, differences in physiological properties between the dental implants and human dental
tissues cause peri-implantitis with alveolar bone loss and periodontal inflammation [1,2]. It
has been reported that approximately 64% of donors experience alveolar bone loss within
two months after dental implant surgery [3]. Therefore, bioengineered 3D tissue constructs,
which use biomaterials and dental cells, have been used to regenerate craniofacial and den-
tal tissues. Many researchers have reported that dental tissue regeneration can be achieved
using tissue engineering approaches [4–7]. However, producing engineered 3D dental
constructs with clinically-relevant sizes, patient-specific shapes, and high regenerative
capacity is a challenge [7–13]. In this respect, 3D bioprinting technology has recently gar-
nered the attention of several researchers. The technology can produce 3D freeform cellular
constructs using various types of living cells, biomolecules, and biomaterials [14]. It allows
the fabrication of patient-specific and macro-sized structures with micro-resolution [15,16].
In addition, biofunctional materials and living cells can be utilized in the technology to
improve tissue regeneration [17–21].
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Human demineralized dentin matrix (DDM) is a promising biomaterial with excellent
bioactive properties that can improve bone and dental tissue regeneration [14–16]. DDM,
prepared by selectively removing minerals from human dentins, consists of biomimetic
chemical components, such as collagen, non-collagen extracellular matrix (ECM) fibers,
and various growth factors [17]. In addition, dentin tubules on the DDM surface are
known to be effective on the delivery of growth factors [14,18]. Based on an in-vivo
study, Li et al. [19] reported that demineralized human dentin can be used to effectively
regenerate engineered dentin tissue. Chen et al. [20] showed that a scaffold consisting of
an aligned electrospun sheet, demineralized human dentin, and dental pulp tissue-derived
extracellular matrix enables the regeneration of dentin-pulp complex and periodontal-like
tissue. Thus, many studies have been reported demonstrating the excellence of DDM for
dental tissue engineering. However, achieving regeneration of patient-specific shaped
dental tissue using conventional approaches can be a complex process because it is difficult
to adjust external shape. In this regard, Athirasala et al. [21] introduced a solubilized DDM-
based bio-ink to 3D print dental tissues; however, it did not show sufficient printability to
produce bioengineered 3D teeth with patient-specific shapes and clinically relevant sizes.
In this study, we developed a new bio-ink for dental tissue engineering using DDM
particles (DDMp) (Figure 1) and a fibrinogen–gelatin mixture that is widely used in bio-
printing technology. Rheological property, 2D/3D printability, and cytocompatibility of
the bio-ink according to the change in DDMp concentration were evaluated and analyzed.
Effect of the DDMp-based bio-inks (DDMp bio-inks) on odontogenic differentiation of
dental pulp stem cells (DPSCs) was also investigated. Finally, DDMp bio-ink was applied
to print a 3D tooth-like cellular construct with patient-specific shape and clinically relevant
size using a computer-aided design (CAD) model.
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Figure 1. Schematic illustration of the preparation of a demineralized dentin matrix particle 
(DDMp) bio-ink for 3D bioprinting. 
2. Materials and Methods 
2.1. Preparation of DDMp Bio-Ink 
t reparation of a demineralized dentin matrix particle (DDMp)
bio-ink for 3D bioprinting.
2. aterials and ethods
2.1. Preparation of DDMp Bio-Ink
DDMp was prepared using human teeth, following the procedure that was reviewed
and approved by the Institutional Review Board of Kyungpook National University (Daegu,
Korea) (KNU 2017-78). Briefly, the tooth periodontium and pulp were removed, and
the dentin was decalcified at 4 ◦C for 4 weeks with a 0.5 M ethylenediaminetetraacetic
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acid(EDTA)(Sigma, St. Louis, MO, USA) solution (pH 8.0) containing protease inhibitors
(Roche, Basel, Switzerland) as described [22]. Then, the dentin was crushed to make dentin
particles [23]. The dentin particles were freeze-milled (Spex Industries, Metuchen, NJ, USA)
and sieved by a 100 µm pore-mesh. A fibrinogen–gelatin mixture composed of fibrinogen
(Sigma, St. Louis, MO, USA), gelatin (Sigma, St. Louis, MO, USA), hyaluronic acid
(HA)(Sigma, St. Louis, MO, USA), and glycerol (Sigma, St. Louis, MO, USA) was prepared
based on a previously reported method [24]. Gelatin, HA, and glycerol were used to
achieve good printability with living cells. Fibrinogen was used to provide a matrix for cell
culturing through crosslinking with thrombin solution, subsequent to printing. To prepare
the mixture, HA (3 mg/mL) was dissolved in modified Eagle’s minimum essential medium
(MEM; Gibco, Waltham, MA, USA). Gelatin (27.5 mg/mL) and fibrinogen (5 mg/mL) were
dissolved into the HA solution (3 mg/mL). Thereafter, glycerol was dissolved to 4% v/v.
The prepared mixture was sterile-filtered (0.45 µm filter; Millipore, Danvers, MA, USA)
and stored at –20 ◦C until used.
Before printing, the frozen mixture was melted in a 37 ◦C water bath (JEIO tech,
Dajeon, Korea). DDMp was sterilized by 70% v/v ethanol (Samchun chemical, Seoul,
Korea) (diluted in distilled water (DW)) for 2 h at 4 ◦C and washed with DW twice.
Subsequently, DDMp was soaked in a growth medium to remove residual ethanol. Finally,
the DDMp and the fibrinogen–gelatin mixture were gently mixed to prepare DDMp bio-ink
at a concentration of 1–10% w/v.
2.2. Cell Culture and Cell-Laden Bio-Ink Preparation
DPSCs (Lonza, Walkersville, MD, USA) were cultured with alpha MEM (Welgene,
Kyungsan, Korea) and supplemented with 10% fetal bovine serum (Capricorn, Hesse,
Germany) and 1% v/v penicillin-streptomycin (P/S; Capricorn, Hesse, Germany) in physi-
ological conditions (37 ◦C, 5% CO2). The growth medium was exchanged every 3 days.
DPSCs were subcultured at 70–80% confluency by dissociation with Tryple ™ Select (1X)
(Gibco, Waltham, MA, USA). StemMACS OsteoDiff media (Miltenyi Biotec, Bergisch Glad-
bach, Germany) containing 1% v/v P/S was used for odontogenic induction of DPSCs. In
the culture of DPSC-laden bio-ink, aprotinin (Sigma, St. Louis, MO, USA) was added to the
culture medium at a concentration of 10 µg/mL to prevent excessive bio-ink degradation.
Before printing, harvested DPSCs were gently and homogeneously mixed with the
prepared DDMp bio-ink (3 × 106 cells/mL). The prepared DPSC-laden-DDMp bio-ink
was filled into a 1 mL syringe (Henke Sass Wolf, Nörten-Hardenberg, Germany) and then
cooled in a 4 ◦C refrigerator for 10 min to induce a hydrogel form. Subsequently, the
syringe was connected to a micro-nozzle (Mitsumi Electric Co. Ltd., Tokyo, Japan) of
300 µm in diameter and installed into the bioprinting system (Supplementary Materials
Figure S1). After the printing process, the DDMp bio-ink was crosslinked with thrombin
solution (10 U/mL) (Sigma, St. Louis, MO, USA) for 30–45 min and then cultured for
further experiments.
2.3. Compressive Modulus and Rheological Property Measurement
Cylindrical samples with a 5 mm diameter and 1 mm height were prepared through
the biopsy punching of crosslinked DDMp bio-inks to measure the compressive modulus.
After loading each sample into a universal testing machine (Instron Model 3342; Illinois
Tool Works Inc., MA, USA), the sample was gradually compressed at a rate of 1 mm/min,
and the corresponding force and distance were recorded. After plotting the strain–stress
curve, the compressive modulus was measured by calculating a slope based on a 10%
strain. In addition, a 3D hybrid construct of 5 × 5 × 5 mm3 produced through the co-
printing of polycaprolactone (s; MW 43000; Polysciences Inc, Warrington, FL, USA) and
DPSCs-laden DDMp bio-ink was measured for the compressive modulus identical to the
DDMp bio-ink. The rheological property of the DDMp bio-inks was measured through
shear sweep analysis, which was conducted at 0.1–100 s−1 using a 20-mm-diameter plate
at 18 ◦C on a HAAKE MARS III Rheometer (Thermo Scientific, Karlsruhe, Germany).
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2.4. Scanning Electron Microscopy (SEM) Imaging
SEM (S-4800; Hitachi High-Technologies, Tokyo, Japan) was used to investigate the
size and morphology of DDM particles. The particles were fixed on a carbon tape and
coated with plutonium at 20 mA for 50 s by using a sputter coater (E-1045; Hitachi High-
Technologies Co., Tokyo, Japan). SEM images were captured at 5.0 kV, and the particle
sizes were measured using the ImageJ software (NIH, Bethesda, MD, USA).
2.5. Bioprinting System and Printability Test
A home-made bioprinting system, which can print cell-laden bio-inks, was used
to evaluate the DDMp bio-inks (Supplementary Materials Figure S1). The printing sys-
tem consists of three-axis stages for motion control, multi-cartridge dispensing modules
for delivering multiple types of cells and biomaterials, and an enclosure for controlling
temperature, humidity, and cleanliness.
The printability of the DDMp bio-inks was evaluated by producing line patterns, and
a stacking test of multiple layers was performed to estimate the ink’s 3D printability. The
stacking ability of the bio-ink is most evident in stacked line structures such as thin walls.
The bio-inks with various concentrations of DDMp were prepared and applied to print line
patterns according to the change in printing speed (5–320 mm/min). After imaging the
line patterns using a microscope (Leica Dml-1, Leica Microsystems AG, Wetzlar, Germany),
their heights and widths were measured using ImageJ software (NIH, Bethesda, MD, USA).
Aspect ratios of the line patterns were calculated by dividing height with width. For
the stacking test of the DDMp bio-inks, samples were prepared by stacking predefined
numbers of line patterns with 400 µm width and 150 µm thickness using the bioprinter.
After imaging the printed samples, their stacked heights were measured using the ImageJ
software. In the printability tests, DDMp bio-inks were extruded at a rate of 34.3 µL/min
through a 300 µm nozzle.
2.6. Cytocompatibility
To measure the viability of the DPSCs in DDMp bio-inks and 3D bio-printed con-
structs, live and dead staining (L3224, Thermo Fisher Scientific, Waltham, MA, USA) was
performed on day 7. The samples were stained with assay solution (0.2% v/v calcein
AM (ThermoFisher Scientific, Waltham, MA, USA) and 0.05% v/v ethidium homodimer-1
(ThermoFisher Scientific, Waltham, MA, USA) in PBS) at room temperature for 1 h and
then imaged using a fluorescent microscope (Leica DM2500, Leica Microsystems AG,
Wetzlar, Germany). After counting the number of live and dead cells, the cell viability was
calculated by dividing the number of live cells by the total cell count.
Proliferation assay was performed using AlamarBlue ™ Cell Viability Reagent (Ther-
moFisher Scientific, Waltham, MA, USA) on days 1, 3, 5, and 7. Bioprinted DPSC-laden
bio-inks were incubated in 10% v/v alamar blue dye diluted by growth medium in an
incubator for 3 h. After sampling the 100 µL assay solution to a 96-well plate, their fluores-
cence intensities (excitation: 544 nm/ emission: 599 nm) were measured using a microplate
reader (Synergy NEO2 Hybrid Multi-Mode Reader; Bio-Tek, Winooski, VT, USA). The
measured data were normalized by the data of the sample obtained on day 1.
2.7. Alizarin Red and Alkaline Phosphate (AP) Staining
Bioprinted DPSC-laden samples were cultured in an odontogenic differentiation
medium for 15 days; alizarin red and AP staining were performed. For the alizarin red
staining, samples were fixed with 4% formaldehyde solution (Junsei, Tokyo, Japan) solution
on day 15 and stained with an alizarin red S (Sigma, St. Louis, MO, USA) solution of 2%
w/v diluted by double DW at pH 4.3 for 20 min. To quantify the mineral deposition, the
stained samples were de-stained with 10% cetylpyridinium chloride (Sigma, St. Louis, MO,
USA) solution in 10 mM sodium phosphate buffer (Sigma, St. Louis, MO, USA) (pH 7.0)
overnight. The optical density of each de-stained sample was measured using a microplate
reader at 550 nm. After de-staining, the samples were observed with a microscope. AP
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staining was performed using REPROCELL Stemgent ®Alkaline Phosphatase (AP) Staining
Kit II (Stemgent, Cambridge, MA, USA), according to the manufacturer’s instruction.
In particular, the samples were fixed for 2–5 min and stained with the prepared AP staining
solution in the dark at room temperature for 5–15 min. Thereafter, the samples were
washed twice with PBS. The stained samples were then imaged with a microscope.
2.8. Immunofluorescence Staining
Immunostaining for dentin sialo-phosphoprotein (DSPP) was performed. Samples,
cultured in the differentiation medium for 15 days, were fixed with 4% PFA for a day. They
were permeabilized with 0.1% Triton X-100 (Sigma, St. Louis, MO, USA) in PBS (Sigma, St.
Louis, MO, USA) for 5 min and blocked with 5% bovine serum albumin (Sigma, St. Louis,
PA, USA) for 1 h. The samples were incubated in the DSPP antibody solution (dilution ratio
1:500; SantaCruz Biotechnology, Dallas, TX, USA) overnight at 4 ◦C. They were washed
with PBS at 4 ◦C overnight. The secondary antibody, Goat Anti-mouse lgG (H+L) Alexa
Fluor 488 (Thermofisher Scientific, Waltham, MA, USA), was diluted in PBS (1:1000) and
incubated with the samples for 1 h at room temperature. The samples were washed three
times with PBS, followed by incubation in 1:1000 diluted Hoechst 33258 (Sigma, St. Louis,
MO, USA) for 3 min. Thereafter, they were observed using a fluorescent microscope.
2.9. RT-qPCR
Messenger ribonucleic acid (mRNA) expression levels of dentin matrix acidic phospho-
protein 1 (DMP-1) and DSPP were measured. Each sample was crushed using bioMasher-II
(Optima, Tokyo, Japan). The samples were treated with Trisure (Bioline, London, UK)
for 10 min and vigorously vortexed for 30 s to isolate the RNA. cDNA for each RNA
sample was synthesized using helixcript™ Thermo Reversed Transcriptase (Nanohelix,
Daejeon, South Korea). Biometra Professional TRIO Thermo-cycler (Analytik Jena AG,
Jena, Germany) was used for the synthesis of cDNA. Then, the cDNA mixed with primers
(Table S1) was amplified with Roche SYBR Light Cycler 480 SYBR Green I Master (Roche
Diagnostics Gmbh, Mannheim, Germany) using a light cycler 480 II (Roche Diagnostics
Gmbh, Mannheim, Germany). Expression levels of DMP-1 and DSPP have been normal-
ized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) via the ∆∆Ct method. All
the experiments were performed in triplicate.
2.10. Bioprinting of 3D Tooth-Shaped Cellular Construct with DDMp Bio-Ink
A tooth-shaped 3D-CAD model was applied to print a patient-specific shaped con-
struct. A motion program was prepared by an in-house computer-aided manufacturing
software and the 3D-CAD model [24]. The motion program was loaded into the bioprinter,
and 3D cellular constructs were produced through an automated process in which layers
of 150 µm thickness were added sequentially in a predefined manner using DPSC-laden
DDMp bio-ink (10% w/v DDMp, 3 × 106 cells/mL) and/or PCL. Bioprinting with DDMp
bio-ink was conducted using a 300 µm nozzle at a dispensing rate and printing speed of
0.5735 µL/s and 50 mm/min, respectively. Polymer printing with PCL was conducted
using a 300 µm nozzle at a dispensing pressure of 200 Kpa at 85 ◦C. A bio-ink-only con-
struct has a height of 3 mm and a bio-ink/PCL hybrid construct has a height of 2 cm. In
the printing processes, the enclosure was maintained at 18 ◦C. Subsequently, the construct
was crosslinked with thrombin (10 U/mL) solution at room temperature for 45 min and
cultured in the incubator.
2.11. Statistical Analysis
All variables are expressed as means ± standard error of the mean. Statistical analyses
were performed using Origin (2020 version, OriginLab Corp., Northampton, MA, USA).
Multiple comparisons between experimental groups were conducted by one-way analysis
of variance and Tukey’s multiple comparison test. In all analyses, p < 0.05 was taken to
indicate statistical significance.
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3. Results
3.1. Preparation and Characterization of DDMp Bio-Ink
DDMp was prepared through demineralization and freeze-milling using human teeth.
The prepared DDMp had irregular polygonal shapes in micro-scale, and dentinal tubule
structures of 2–4 µm diameter were well maintained on the surfaces (Figure 2a). From
the measured particle size, the average size of the prepared DDMp was approximately
48.13 µm, of which 20–60 µm sized particles accounted for 62.73% of the total (Figure 2b).
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DD p bio-inks ere prepared by ixing the DD p ith the fibrinogen–gelatin
ixture. The icroscope i age sho ed that the particles in the bio-inks did not for
aggregates and ere homogeneously distributed (Figure 2c). After preparing DDMp
bio-inks of 1 , 3 , 5%, and 10% w/v concentration, their viscosities were measured. The
viscosity of the bio-ink increased with the concentration of DDMp. Additionally, t e s ear-
t i i properties of the bio-inks were reinforced; the viscosity decreased with increasing
shear rate (Figure 2d), as the DDMp concentration increased. The DDMp con e tration
directly affected the m chanical pro erty of the crosslinked bio-ink. Its co pressive
l s increased with DDMp con e tration (Figure 2e). The modulus of 10% w/v DDMp
bio-ink was approximately 16.3 times higher than that of the fibrinogen–gelatin mixture.
Statistical significance was also observed.
3.2. Cytocompatibility of DDMp Bio-Ink
DPSCs were applied to investigate the cytocompatibility of the DDMp bio-ink. Live/
dead staining results showed that most of the DPSCs were alive in all bio-ink groups
regardless of DDMp concentration at day 7 (Figure 3a). Quantification results of the
staining indicated greater than 95% cell viability in all groups (Figure 3b). Notably, a
significant increase in the DPSC density was observed on and around the DDMp surface in
the bio-ink (Supplementary Materials Figure S2). A slightly different trend was observed
in the evaluation result of DPSC proliferation, which was performed using an alamar
blue assay. All bio-ink groups continued to proliferate for 7 days; however, the DPSC
proliferation rate decreased as the DDMp concentration increased (Figure 3c).
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Figure 4. Odontogenic differentiation of DPSC-laden DDMp bio-ink. (a) Bright field microscopy images and alizarin red
staining result of DPSC-laden DDMp bio-inks after culturing with differentiation medium for 15 days. White arrowheads
indicate the formation of mineral nodules (Scale bar: 300 µm). (b) Quantification result of alizarin red stained samples
(n = 4) (* p < 0.05; ** p < 0.01).
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3.4. Printability of DDMp Bio-Ink
We evaluated the 2D and 3D printability of the DDMp bio-inks. For the 2D printability
test, line patterns were printed with a 300 µm nozzle and the line width and height were
measured. The printed line width gradually decreased as the printing speed increased
(Figure 5a). Notably, continuous line patterns were produced more stably as the DDMp
concentration increased. The fibrinogen–gelatin mixture group (0% w/v DDMp) produced
broken lines at 160 mm/min printing speed, while the 10% w/v DDMp bio-ink group
produced a continuous line even at 320 mm/min. Based on the continuous line patterns,
the fibrinogen–gelatin mixture and 10% w/v DDMp bio-ink group showed minimum
widths of approximately 360 and 252 µm, respectively (Figure 5b). This result indicated
that the printing resolution of the 10% w/v DDMp bio-ink is higher than the other bio-
inks. A decreasing trend with increasing printing speed was observed in all groups in the
measured line width and height based on the microscope images (Figure 5c,d). As the
DDMp concentration increased, the printed line width decreased and the height increased.
This tendency was observed more clearly in the calculation result of aspect ratio (Figure 5e).
Based on the 320 mm/min printing speed, the 10% DDMp bio-ink and fibrinogen–gelatin
mixture group had an aspect ratio of 0.707 and 0.326, respectively.
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Figure 5. Printability test of DDMp bio-inks. (a) Microscopy image of line patterns print d wi h DDMp bio-inks according
to the change of printing speed (scale bar: 1 mm). White a rows indicate disconnected points in t e printed lines. Measured
results of printable minimum (min.) line width (b), line width (* p < 0.05; *** < 0.001), (c) and height (d) of the printed lines
(n = 10). Min. line width refers to the smallest width among continuous line patterns pr t d without breaking. (e) Aspect
ratios of the printed lines, which were calculated using the measured line widths and heights.
In the stacking test of the line patterns, a similar trend was observed with the 2D
printing test results. The layer-by-layer process was conducted with a line pattern of
400 µm width and 150 µm thickness. The stacked thickness continued to increase as the
number of layers stacked increased in all groups (Figure 6a). Furthermore, DDMp affected
the stacked thickness. The thickness increased as the DDMp concentration increased. The
measurement results of the thickness based on the microscopy images show this trend more
clearly (Figure 6b). There was no significant difference between the fibrinogen–gelatin
mixture and the 1% w/v DDMp bio-ink group; however, for above 3% w/v, the stacked
height significantly increased as the DDMp concentration increased. Finally, the 10%
DDMp bio-ink was applied to produce multilayered hydrogel structures. The layer-by-
layer process was conducted using the tooth-shaped porous pattern of 2 cm height and
150 µm thickness. The printed hydrogel structure retained the pores suitably without
collapse, even for the stacking process involving 20 layers (Figure 6c).
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Figure 6. Stacking test of DDMp bio-inks. Microscopy images (scale bar: 5 mm) (a) and measured heights (b) of multilayered
structures printed with DDMp bio-inks in the change of the number of stacked layers (n = 6), (c) visualized printing code
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10 mm). The visualized code indicates the printing paths to produce the designed 3D structure. ** p < 0.01; *** p < 0.001.
3.5. Bioprinting of Human Tooth-Shaped 3D Construct with DPSCs
We investigated that 3D tooth-shaped cellular constructs can be fabricated through
co-printing of DPSC-laden DDMp bio-ink and PCL. A motion program required for the
printing process was prepared using a tooth CAD model and home-made software [24].
A 3D tooth-shaped scaffold of 2 cm height was produced through PCL printing, and
a DPSC-laden DDMp bio-ink was printed inside it (Figure 7a,b). The pattern of the
DDMp bio-ink printed inside the PCL scaff ld was stably aintained. The viability
and odontogenic differentiation of DPSCs within the printed construct were evaluated.
Construct printed with DPSC-laden fibrinogen–gelatin mixture was used as a control
group. Owing to live/dead staining after culturing in growth medium for 7 days, most
DPSCs were alive i both the groups (fibrinogen–gelatin mixture and DDMp bio-ink group)
(Figure 7c). This result is consistent with that depicted in Figure 3b. After culturing in a
differentiation medium for 15 days, odontogenic differentiation of the printed tooth-shape
construct was evaluated. Alizarin red staining results showed that mineralization was
significantly higher in the DDMp bio-ink group than in the fibrinogen–gelatin mixture
group (Fig re 7d). This result is cons stent with that shown in Figure 4. DSPP and DMP-1
expression levels, which are specific markers of odontogenic differentiation, were also
measured through RT-qPCR. The group printed with the DDMp bio-ink showed 22.86
and 59.76 times higher DSPP and DMP-1 expression than the fibrinogen–gelatin mixture
group, respectively (Figure 7e). Statistical sig ificance was also observed. Furthermore,
immunostaining results indicated that AP and DSPP expression was higher around the
DDM particle in the bio-ink (Supplementary Materials Figure S4). Finally, the compressive
modulus of the cellular construct was measured. A 5 × 5 × 5 mm3 cube with an identical
inner architecture as the tooth-shaped construct was prepared for compression testing. The
measurement results indicated that the PCL-DDMp bio-ink hybrid construct possessed
a compressive modulus of approximately 30 MPa, similar to the PCL scaffold (Figure 7f).
Alternatively, the hydrogel construct composed of the DDMp bio-ink possessed a modulus
of approximately 25 KPa, which was 1165 times lower than that of the hybrid construct.
These results indicated that the mechanical property of the 3D tooth-shaped cell structure
was mainly determined by the PCL structure.
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4. Discussion
In dental tissue engineering, the development of engineered dental tissue with patient-
specific shape and clinically relevant size is an important issue [25–28]. In this regard,
various studies have been conducted to apply bioprinting technology, capable of producing
3D freeform structure using various cells and biomaterials, in dental tissue engineering [29].
DDM is one of the most promising biomaterials in dental tissue engineering because of
its excellent performance in dental tissue regeneration [16,18–21,23,30]. Various DDM-
based materials have been developed. However, DDM-based bio-ink possessing sufficient
printability to produce patient-specific shapes and sizes for dental tissue engineering has
not been developed yet. I his study, we developed a novel DDM particle-based bio-ink
(DDMp bio-ink) that xhibits not only good performance in dental tissue regeneration but
also excellent printability.
The fabricated DDMp bio-ink significantly promoted odontogenic differentiation of
dental cells. Therefore, the effect of the bio-ink on odontogenic differentiation of DPSCs
was investigated. The results indicated that the DDMp bio-ink enhanced the DSPP, DMP-
1, and AP expressions and mineralization of DPSCs, which are known as markers of
odontogenic differentiation (Figures 4 and 7d–e, Supplementary Materials Figures S3 and
S4) [31–36]. DPSCs in 10% w/v DDMp bio-ink possessed polygonal morphologies and
their proliferation rate decreased with increasing DDMp concentration (Figure 3a,c and
Figure 7c). This phenomenon was observed during odontogenic differentiation of DPSCs.
Similar to results we achieved, Al-Sharabi et al. [37] reported that human dental pulp
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cells possessed polygonal morphologies with reduced proliferation rate in an odontogenic
induction medium. Human tooth-derived DDM is known to contain various biochemical
factors such as BMP-2, TGF-ß, and bFGF [14,16,18,22,23,38]. It is interpreted that the
biochemical factors possessed by DDM particles in the bio-ink promoted the odontogenic
differentiation of DPSCs.
The DDM particles enhanced the 3D printability of the bio-ink. DDM particles im-
proved the bioprinting resolution of the fibrinogen–gelatin mixture. As the DDM particle
content in the bio-ink increased, printing a smaller line width became possible. The mini-
mum line width that could be produced with 10% w/v DDMp bio-ink was approximately
252 µm, while the fibrinogen–gelatin mixture was approximately 363 µm (Figure 5b). In ad-
dition, DDM particles improved the stacking ability of the bio-ink. Our DDMp bio-ink
was able to stack more than 20 layers with line patterns without any additional supporting
material (Figure 6a,b). Conversely, DDM-based bio-inks introduced by other researchers
exhibited only four layers of stacking results [39]. This stacking ability has a great influence
on reliably performing layer-by-layer process for 3D printing. The improved resolution
and stacking ability of the DDMp bio-ink is because the DDM particles reinforced the vis-
cosity and shear-thinning behavior of the bio-ink (Figure 2d) [40]. Shear-thinning behavior
refers to the phenomenon in which the viscosity increases as the shear rate decreases. This
property is one of the most important properties of bio-ink in that it reduces the shear stress
acting on cells during the extrusion process for bioprinting and improves shape retention
of bioprinted structures [41–43].
Finally, we demonstrated that the possibility of fabricating a 3D cellular construct with
patient-specific shape and size through co-printing of DDMp bio-ink and PCL (Figure 7a,b).
Within the printed construct, DPSCs showed high viability for seven days, and enhanced
odontogenic differentiation was also observed (Figure 7d–f). This result indicates that PCL
printed at 85 ◦C did not cause significant thermal damage to DPSCs. This is because the PCL
material was printed into a microstructure and subsequently was rapidly cooled down in an
environment with a room temperature of 18 ◦C. These results are consistent with previous
cases of co-printing of cell-laden bio-ink and PCL [24,44–46]. Our DDMp bio-ink/PCL
hybrid construct exhibited a compressive modulus of approximately 29.8 MPa, which is
lower than that of native dentin tissue [47]. The hybrid structure exhibited a compressive
modulus similar to that of the PCL-only construct, which means that the mechanical properties
of the hybrid structure mainly depended on the PCL frame (Figure 7f). In our future study,
we plan to develop a co-printing process of DDMp bio-ink and high-strength material, such
as ceramics, to enhance mechanical properties of the engineered dental tissues. Moreover, we
plan to verify the feasibility and efficacy of the bioprinted 3D dental construct in dental tissue
regeneration through in vivo studies.
5. Conclusions
In this study, a new DDMp bio-ink was developed for dental tissue engineering by
mixing human tooth-derived DDMp with a fibrinogen–gelatin mixture. The DDMp bio-ink
could be applied to produce 3D structures through a layer-by-layer process with 2D micro-
patterning using living dental cells. The DDMp bio-ink significantly improved in-vitro
odontogenic differentiation of DPSCs. A CAD model-based 3D cellular construct of 2 cm
height was produced using the proposed bio-ink. This demonstrated that the proposed
bio-ink can be applied to bioprint-engineered 3D dental constructs with patient-specific
shapes and clinically relevant size. The proposed technology can be regarded as a useful
tool in dental tissue engineering.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/polym13081294/s1. Supplementary Materials Figure S1: Schematic diagram and photograph
of a home-made 3D bioprinter, Figure S2: Fluorescence images of DPSCs in 10% w/v DDMp bio-ink
on days 1, 5, and 10, Supplementary Materials Figures S3–S4: Odontogenic differentiation of DPSCs
in DDMp bio-ink. Supplementary Materials Table S1: Primer sequences.
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